Evaluating Access My Breast Cancer Care App to Support Breast Cancer Patients in Navigation, Satisfaction, and Care Efficiency

What this Trial Is About

Researchers are evaluating the Access My Breast Cancer Care application, designed to support patients undergoing breast cancer surgery with reconstruction. This randomized controlled trial aims to assess whether the app improves patient navigation, satisfaction with care, and care delivery efficiency. The study also explores the apps usability and its impact on reducing in-person specialist visits and time to specialist review. Participants are randomly assigned to one of two groups one receiving standard breast cancer care and the other receiving standard care plus access to the app. The app offers educational resources, a calendar, symptom tracking, a customizable care pathway, a community forum, and a chat feature. The trial includes mixed methods with both quantitative and qualitative data collected, including BREAST-Q scores and app usage metrics. During the study, participants will be monitored for patient-centered outcomes such as satisfaction with care, reduction in adverse events, and usability of the app at 1 and 6 months. Researchers will track the number of emergency room visits, wait times for specialist reviews, and app engagement. Focus groups will be conducted to gather patient perspectives on the apps benefits. The study aims to complete by September 2027.

Access My Breast Cancer Care App